Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Redburn Partners Initiates Coverage On Sabre with Buy Rating

Redburn Partners Initiates Coverage On Sabre with Buy Rating

Redburn Partners analyst James Goodall initiates coverage on Sabre (NASDAQ:SABR) with a Buy rating.

byBenzinga Newsdesk

September 28, 2022

1 minute read

Redburn Partners analyst James Goodall initiates coverage on Sabre (NASDAQ:SABR) with a Buy rating.

Analyst Ratings

Beyond The Numbers: 22 Analysts Discuss Texas Roadhouse Stock

By Benzinga Insights

May 28, 10:00 AM

In the last three months, 22 analysts have published ratings on Texas Roadhouse (NASDAQ:TXRH), offering a diverse range…

TXRH

Papa John’s Near-Term Outlook Too Appealing To Ignore, Analyst Upgrades To Outperform

By Lekha Gupta

September 1, 2:13 PM

Wedbush analyst Nick Setyan upgraded Papa John's International Inc (NASDAQ: PZZA) to Outperform from Neutral at an

PZZA

EXCLUSIVE: Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia

By Vandana Singh

December 28, 8:31 AM

Alzamend Neuro Inc (NASDAQ: ALZN) has partnered with the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for its Phase 1/2A trial of ALZN002.

ALZN

Analyst Ratings

What 8 Analyst Ratings Have To Say About American Tower

By Benzinga Insights

July 18, 10:06 AM

American Tower (NYSE:AMT) has observed the following analyst ratings within the last quarter:

AMT

Redburn Partners Initiates Coverage On Sabre with Buy Rating

Related Posts

Beyond The Numbers: 22 Analysts Discuss Texas Roadhouse Stock

Papa John’s Near-Term Outlook Too Appealing To Ignore, Analyst Upgrades To Outperform

EXCLUSIVE: Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia

What 8 Analyst Ratings Have To Say About American Tower